病原体类型对二期置换关节成形术再植入理想时机的影响
这项回顾性研究纳入451例慢性膝关节假体周围感染行二期置换的患者,用ROC曲线分析不同病原体的最佳间隔时间。高毒力病原体129天、甲氧西林敏感金黄色葡萄球菌117天、培养阴性98天、凝固酶阴性葡萄球菌86天;超过各自界值可预测治疗失败。
要点
- 最佳间隔时间因病原体而异:高毒力129天、MSSA 117天、培养阴性98天、CoNS 86天。
- 各病原体间隔时间超过对应界值是治疗失败的预测因素(均P<0.05)。
- 研究为回顾性、Level III证据,需更大样本验证。
核心结论
- 二期置换中理想间隔时间因感染病原体类型不同而差异明显,超过各病原体对应界值可预测治疗失败。
研究设计与样本
- 回顾性研究,纳入576例慢性膝关节假体周围感染行二期置换患者,排除间隔>180天(n=76)及更换间隔物(n=49)者,最终分析451例,平均随访5.8年。
主要发现
- 451例中71例(15.7%)治疗失败,380例(84.3%)成功。
- ROC分析显示最佳间隔时间:高毒力病原体129天,甲氧西林敏感金黄色葡萄球菌117天,培养阴性98天,凝固酶阴性葡萄球菌86天。
- 多因素回归控制协变量后,各病原体间隔时间超过对应界值是治疗失败的预测因素(均P<0.05)。
关键数值与推荐
- PJI定义采用2013年肌肉骨骼感染学会标准。
- 治疗失败定义为因感染再次手术或PJI相关死亡。
- 高毒力病原体最佳间隔129天,MSSA 117天,培养阴性98天,CoNS 86天。
临床怎么用
- 临床可参考病原体类型个体化确定再植入时机,高毒力病原体可能需要更长间隔。
- 对培养阴性PJI和CoNS感染,可考虑相对较短的间隔时间。
局限性
- 回顾性设计,证据等级为Level III。
- 排除了间隔>180天及更换间隔物者,可能限制结论外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To our knowledge, no study to date has examined the association between organism profile and ideal interstage duration in patients undergoing two-stage exchange arthroplasty. The purpose of this study was to evaluate the impact of the type of infecting organism on the optimal timing of reimplantation in this patient population. METHODS: This retrospective study identified 576 patients who had a chronic periprosthetic joint infection (PJI) of the knee and underwent two-stage exchange arthroplasty with a minimum one-year follow-up. A PJI was defined using the 2013 Musculoskeletal Infection Society criteria. Patients who had a time to reimplantation greater than 180 days from resection arthroplasty (n = 76) and those who underwent spacer exchange were excluded (n = 49). Treatment failure was defined as any reoperation for infection or PJI-related mortality. Receiver operator characteristic curve analyses were used to identify whether the optimal interstage duration differed by infecting organism. Multivariate regression analyses were performed to identify the risk factors for failure. There were 451 patients included who had a mean follow-up time of 5.8 years. RESULTS: Of the 451 included patients, 71 (15.7%) patients experienced failure and 380 (84.3%) experienced success. The Receiver operator characteristic curve analyses demonstrated that the optimal interstage duration was longest for patients infected with "high-virulence" pathogens (129 days), followed by those who had methicillin-sensitive Staphylococcus aureus (117 days), culture-negative PJI (98 days), and coagulase-negative Staphylococci (86 days). After controlling for covariates, regression analyses showed that an interstage duration above the identified cutoff for each pathogen group was a predictor of treatment failure (all P < 0.05). CONCLUSIONS: We found that the ideal interstage duration varied considerably by the type of infecting organism in patients undergoing two-stage exchange. Greater awareness of this data may help guide the optimal timing of reimplantation in this patient population. LEVEL OF EVIDENCE: Level III.
引用
- Tarabichi S, Paul BR, Verhey JT, et al. Impact of Organism Profile on Ideal Timing of Reimplantation in Patients Undergoing Two-Stage Exchange Arthroplasty. J Arthroplasty. 2026. PMID: 42617924. doi:10.1016/j.arth.2026.08.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。